138 related articles for article (PubMed ID: 9804811)
1. Determination of the affinity and kinetic constants for the interaction between the human virus echovirus 11 and its cellular receptor, CD55.
Lea SM; Powell RM; McKee T; Evans DJ; Brown D; Stuart DI; van der Merwe PA
J Biol Chem; 1998 Nov; 273(46):30443-7. PubMed ID: 9804811
[TBL] [Abstract][Full Text] [Related]
2. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation.
Powell RM; Ward T; Evans DJ; Almond JW
J Virol; 1997 Dec; 71(12):9306-12. PubMed ID: 9371589
[TBL] [Abstract][Full Text] [Related]
3. Structural and functional insights into the interaction of echoviruses and decay-accelerating factor.
Pettigrew DM; Williams DT; Kerrigan D; Evans DJ; Lea SM; Bhella D
J Biol Chem; 2006 Feb; 281(8):5169-77. PubMed ID: 16272562
[TBL] [Abstract][Full Text] [Related]
4. Short consensus repeat domain 1 of decay-accelerating factor is required for enterovirus 70 binding.
Karnauchow TM; Dawe S; Lublin DM; Dimock K
J Virol; 1998 Nov; 72(11):9380-3. PubMed ID: 9765493
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding.
Clarkson NA; Kaufman R; Lublin DM; Ward T; Pipkin PA; Minor PD; Evans DJ; Almond JW
J Virol; 1995 Sep; 69(9):5497-501. PubMed ID: 7543583
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of the epidermal growth factor-like short consensus repeat domain-mediated protein-protein interactions: dissection of the CD97-CD55 complex.
Lin HH; Stacey M; Saxby C; Knott V; Chaudhry Y; Evans D; Gordon S; McKnight AJ; Handford P; Lea S
J Biol Chem; 2001 Jun; 276(26):24160-9. PubMed ID: 11297558
[TBL] [Abstract][Full Text] [Related]
7. Coxsackieviruses B1, B3, and B5 use decay accelerating factor as a receptor for cell attachment.
Shafren DR; Bates RC; Agrez MV; Herd RL; Burns GF; Barry RD
J Virol; 1995 Jun; 69(6):3873-7. PubMed ID: 7538177
[TBL] [Abstract][Full Text] [Related]
8. The structure of echovirus type 12 bound to a two-domain fragment of its cellular attachment protein decay-accelerating factor (CD 55).
Bhella D; Goodfellow IG; Roversi P; Pettigrew D; Chaudhry Y; Evans DJ; Lea SM
J Biol Chem; 2004 Feb; 279(9):8325-32. PubMed ID: 14634014
[TBL] [Abstract][Full Text] [Related]
9. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55).
Bergelson JM; Mohanty JG; Crowell RL; St John NF; Lublin DM; Finberg RW
J Virol; 1995 Mar; 69(3):1903-6. PubMed ID: 7531780
[TBL] [Abstract][Full Text] [Related]
10. Determination of the structure of a decay accelerating factor-binding clinical isolate of echovirus 11 allows mapping of mutants with altered receptor requirements for infection.
Stuart AD; McKee TA; Williams PA; Harley C; Shen S; Stuart DI; Brown TD; Lea SM
J Virol; 2002 Aug; 76(15):7694-704. PubMed ID: 12097583
[TBL] [Abstract][Full Text] [Related]
11. Interaction of decay-accelerating factor with echovirus 7.
Plevka P; Hafenstein S; Harris KG; Cifuente JO; Zhang Y; Bowman VD; Chipman PR; Bator CM; Lin F; Medof ME; Rossmann MG
J Virol; 2010 Dec; 84(24):12665-74. PubMed ID: 20881044
[TBL] [Abstract][Full Text] [Related]
12. Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59.
van der Merwe PA; Barclay AN; Mason DW; Davies EA; Morgan BP; Tone M; Krishnam AK; Ianelli C; Davis SJ
Biochemistry; 1994 Aug; 33(33):10149-60. PubMed ID: 7520278
[TBL] [Abstract][Full Text] [Related]
13. More recent swine vesicular disease virus isolates retain binding to coxsackie-adenovirus receptor, but have lost the ability to bind human decay-accelerating factor (CD55).
Jimenez-Clavero MA; Escribano-Romero E; Ley V; Spiller OB
J Gen Virol; 2005 May; 86(Pt 5):1369-1377. PubMed ID: 15831949
[TBL] [Abstract][Full Text] [Related]
14. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry.
Shafren DR; Dorahy DJ; Ingham RA; Burns GF; Barry RD
J Virol; 1997 Jun; 71(6):4736-43. PubMed ID: 9151867
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of differential receptor usage for naturally occurring CD55-binding and -nonbinding coxsackievirus B3 strains.
Wang Q; Yang Q; Liu C; Wang G; Song H; Shang G; Peng R; Qu X; Liu S; Cui Y; Wang P; Xu W; Zhao X; Qi J; Yang M; Gao GF
Proc Natl Acad Sci U S A; 2022 Jan; 119(4):. PubMed ID: 35046043
[TBL] [Abstract][Full Text] [Related]
16. Mapping the binding domains on decay accelerating factor (DAF) for haemagglutinating enteroviruses: implications for the evolution of a DAF-binding phenotype.
Powell RM; Ward T; Goodfellow I; Almond JW; Evans DJ
J Gen Virol; 1999 Dec; 80 ( Pt 12)():3145-3152. PubMed ID: 10567645
[TBL] [Abstract][Full Text] [Related]
17. Kinetics and thermodynamics of virus binding to receptor. Studies with rhinovirus, intercellular adhesion molecule-1 (ICAM-1), and surface plasmon resonance.
Casasnovas JM; Springer TA
J Biol Chem; 1995 Jun; 270(22):13216-24. PubMed ID: 7768920
[TBL] [Abstract][Full Text] [Related]
18. Equilibrium and kinetics of Sin Nombre hantavirus binding at DAF/CD55 functionalized bead surfaces.
Buranda T; Swanson S; Bondu V; Schaefer L; Maclean J; Mo Z; Wycoff K; Belle A; Hjelle B
Viruses; 2014 Mar; 6(3):1091-111. PubMed ID: 24618810
[TBL] [Abstract][Full Text] [Related]
19. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor.
Powell RM; Schmitt V; Ward T; Goodfellow I; Evans DJ; Almond JW
J Gen Virol; 1998 Jul; 79 ( Pt 7)():1707-13. PubMed ID: 9680134
[TBL] [Abstract][Full Text] [Related]
20. Coxsackie B viruses that use human DAF as a receptor infect pig cells via pig CAR and do not use pig DAF.
Spiller OB; Goodfellow IG; Evans DJ; Hinchliffe SJ; Morgan BP
J Gen Virol; 2002 Jan; 83(Pt 1):45-52. PubMed ID: 11752699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
